Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach

Detalles Bibliográficos
Autores principales: Liu, Shuaibing, Wang, Ziteng, Tian, Xin, Cai, Weimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086405/
https://www.ncbi.nlm.nih.gov/pubmed/33935793
http://dx.doi.org/10.3389/fphar.2021.668861
_version_ 1783686515892682752
author Liu, Shuaibing
Wang, Ziteng
Tian, Xin
Cai, Weimin
author_facet Liu, Shuaibing
Wang, Ziteng
Tian, Xin
Cai, Weimin
author_sort Liu, Shuaibing
collection PubMed
description
format Online
Article
Text
id pubmed-8086405
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80864052021-05-01 Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach Liu, Shuaibing Wang, Ziteng Tian, Xin Cai, Weimin Front Pharmacol Pharmacology Frontiers Media S.A. 2021-04-16 /pmc/articles/PMC8086405/ /pubmed/33935793 http://dx.doi.org/10.3389/fphar.2021.668861 Text en Copyright © 2021 Liu, Wang, Tian and Cai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Shuaibing
Wang, Ziteng
Tian, Xin
Cai, Weimin
Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_full Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_fullStr Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_full_unstemmed Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_short Corrigendum: Predicting the Effects of CYP2C19 and Carboxylesterases on Vicagrel, a Novel P2Y12 Antagonist, by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Approach
title_sort corrigendum: predicting the effects of cyp2c19 and carboxylesterases on vicagrel, a novel p2y12 antagonist, by physiologically based pharmacokinetic/pharmacodynamic modeling approach
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086405/
https://www.ncbi.nlm.nih.gov/pubmed/33935793
http://dx.doi.org/10.3389/fphar.2021.668861
work_keys_str_mv AT liushuaibing corrigendumpredictingtheeffectsofcyp2c19andcarboxylesterasesonvicagrelanovelp2y12antagonistbyphysiologicallybasedpharmacokineticpharmacodynamicmodelingapproach
AT wangziteng corrigendumpredictingtheeffectsofcyp2c19andcarboxylesterasesonvicagrelanovelp2y12antagonistbyphysiologicallybasedpharmacokineticpharmacodynamicmodelingapproach
AT tianxin corrigendumpredictingtheeffectsofcyp2c19andcarboxylesterasesonvicagrelanovelp2y12antagonistbyphysiologicallybasedpharmacokineticpharmacodynamicmodelingapproach
AT caiweimin corrigendumpredictingtheeffectsofcyp2c19andcarboxylesterasesonvicagrelanovelp2y12antagonistbyphysiologicallybasedpharmacokineticpharmacodynamicmodelingapproach

Ejemplares similares